Citi Pharma Ltd

KAR:CPHLHealth TechnologyPSX:ALLSHRPSX:KMI30

Rs 62.35+1.12%LiveIn session · ≈ AED 0.8274 · Market cap $51.79M · Next earnings Wed 2 Dec

CPHL · Cash flow · TradingHolo

PKR millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Depreciation & amortization	52.3	65.7	76.8	90.6	138.2	168.1	186.4	+10.9%
Change in working capital	(131.4)	264.0	(1,221.6)	(1,142.5)	279.9	(1,378.1)	(2,080.4)	−51.0%
Operating cash flow	94.1	745.8	(323.0)	(329.0)	1,337.6	(320.7)	(691.0)	−115.5%
Capital expenditure	(115.2)	(276.7)	(600.5)	(954.5)	(568.2)	(150.1)	(50.7)	+66.2%
Dividends paid	0.0	0.0	(311.5)	0.0	(571.2)	(739.8)	(799.6)	−8.1%
Free cash flow	(21.1)	469.1	(923.4)	(1,283.5)	769.4	(470.8)	(741.7)	−57.6%

PKR millionsUpdated 30 Jun 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-03-31 and uses four consecutive reported quarters.